News & Events

Phosphorex to Host a Virtual Panel Discussion Exploring Targeted Lipid Nanoparticle Development for Extrahepatic Delivery

Phosphorex Names John Rigg Chairman of the Board

Phosphorex Exhibits at ASGCT 2026

Phosphorex Participates in the LNP Formulation & Process Development Summit 2026

LNP Alliance Launches New Website Focused on Advancing LNP Innovation and Collaboration

Phosphorex Appoints Jerry Williamson as Chief Executive Officer

HOPKINTON, Mass., Sept. 19, 2022 /PRNewswire/ — Followi capital investment from Ampersand Capital Partners, Phosphorex, a drug contract developm e nt and manufacturing organization (“CDMO”) providin polymer / lipid nanoparticles , announced today the appointment of Jarl Executive Officer.